6533b7dcfe1ef96bd12728ae
RESEARCH PRODUCT
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks: An Open-Label Extension Study of the COMPACT Trial
Jacques HébertWilliam H. YangClive GrattanConstance H. KatelarisTeresa CaballeroIftikar HussainDonald LevyMarco CicardiWilliam R. LumryAvner ReshefDipti PawaskarInmaculada Martinez-saguerHilary LonghurstJonathan A. BernsteinMichael R. ManningLawrence B. SchwartzHenriette FarkasTimothy J. CraigTimothy J. CraigMaria L. BaezaSergio NeriEmel Aygören-pürsünJana HanzlikovaGordon SussmanPetra Staubach-renzJohn AndersonIoana CrisanIris JacobsCompact InvestigatorsSandra C. ChristiansenSarah MycroftMaria Dolores HernandezMarkus MagerlMarc A. RiedlHenrike FeuersengerPaul K. KeithKonrad BorkHenry LiBruce L. ZurawJoshua J. JacobsShmuel KivityIngo Pragstsubject
medicine.medical_specialtybiologybusiness.industryC1 Esterase Inhibitor ProteinExtension studymedicine.diseaseC1-inhibitorInternal medicineHereditary angioedemabiology.proteinLong term outcomesMedicineOpen labelbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2018-01-01 | SSRN Electronic Journal |